Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8227432 Transposon system and methods of use

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Zongbin Cui0

Geyi Liu0

Karl J. Clark0

Perry B. Hackett0

Adam J. Dupuy0

Aron M. Geurts0

Date of Patent

July 24, 2012

0

Patent Application Number

104205290

Date Filed

April 22, 2003

0

Patent Citations Received

US Patent 12060585 Expression of novel cell tags

0

US Patent 11913075 Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer

0

US Patent 11939637 Molecular biomarkers for cancer immunotherapy

0

US Patent 11957695 Methods and compositions targeting glucocorticoid signaling for modulating immune responses

0

US Patent 11963966 Compositions and methods for treating ovarian tumors

0

US Patent 11965892 HLA-based methods and compositions and uses thereof

0

US Patent 11981922 Methods and compositions for the modulation of cell interactions and signaling in the tumor microenvironment

0

US Patent 11994512 Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity

0

...

Patent Primary Examiner

0

Patent abstract

The present invention is directed to improved transposons and transposases. The present invention also includes gene transfer systems, methods of using the transposons and transposases, and compositions including the transposons and transposases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8227432 Transposon system and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.